Finance
Key steps for impactful communication
New advances in the life sciences shouldn’t be kept in the dark. Whether you are an academic publishing a paper, […] November 15, 2023 · BioVox
The rise of women’s health
It’s been a Barbie world this summer with crowds of pink-clad moviegoers flooding the cinemas. Simultaneously, we’ve been witnessing a […] November 15, 2023 · V-Bio Ventures
Muna Therapeutics: hopeful solutions for memory loss
Muna Therapeutics is developing transformative therapies for neurodegenerative diseases. These drugs aim to preserve cognition and enhance the brain’s resilience […] October 17, 2023 · V-Bio Ventures
One event, uniting Belgium’s regions
BioWin and MEDVIA are two Belgian organizations which support and promote health innovation in Wallonia and Flanders. This year, these […] October 17, 2023 · Janssen Pharmaceutica
V-Bio Ventures Portfolio Company Agomab Raises $100 Million Series C to Advance Fibrosis-focused Pipeline
— Round led by Fidelity Management & Research Company with participation from new investors EQT Life Sciences, Canaan and Dawn […] October 11, 2023 · V-Bio Ventures
miDiagnostics announces collaboration with Galapagos to develop closed-flow, ultra-rapid CAR-T sterility test for its point-of-care CAR-T manufacturing platform
Leuven, Belgium, November 10, 2023 – miDiagnostics NV, a global technology leader in point-of-care diagnostics, today announced a collaboration agreement […] November 10, 2023 · Quality by Design - Business & Communications
Belgium needs boldness for healthcare innovation
This year, Science for health will explore the inspiring innovations at the interface of biology and technology. The event will […] September 27, 2023 · Janssen Pharmaceutica
Hearts in space: a Belgian story of successful collaboration
AstroCardia has developed a heart-on-a-chip to study cardiovascular aging… in space! Trials will begin in 2025 aboard the International Space […] September 26, 2023 · MEDVIA
Lean years for company creation in Europe?
After an exceptional sequence of socio-economic shocks over the past few years, the number of new companies being formed in […] September 27, 2023 · V-Bio Ventures
V-Bio Ventures portfolio company Orionis Biosciences announces collaboration with Genentech to discover and develop molecular glue class medicines
September 20, 2023, BOSTON, MA and GHENT, Belgium – Orionis Biosciences, a privately held life sciences company with an integrated […] September 20, 2023 · V-Bio VenturesV-Bio Ventures portfolio company Corteria Pharmaceuticals raises EUR 65 million to advance its transformational medicines for cardiovascular diseases
Ghent, Belgium, 7 September 2023 – Corteria Pharmaceuticals, a V-Bio Ventures portfolio company, is a biopharmaceutical company specialized in the […] September 7, 2023 · V-Bio Ventures
Johan Cardoen’s hopes for the future of agriculture
Flanders is home to one of the world’s most innovative agrifood clusters, and Johan Cardoen has been a central figure […] August 23, 2023 · BioVox
Fermenting a more sustainable future
In the battle against the climate crisis, precision fermentation presents a hopeful aid. Using microbes to create valuable materials, we […] August 23, 2023 · V-Bio Ventures